DELVE BLOG

Most of us agree that a clinical trial’s success depends heavily on patient engagement. The importance of design patient-centric studies cannot be understated. Engaged patients make for successfully completed studies—with better quality data and more accurate results in general. SMS and other messaging apps seamlessly integrate into clinical trials, increasing patient compliance and patient retention—the automation increases efficiency and saves study teams time, while also reducing costs for sites/sponsors overall. Take advantage of one of the most utilized features on a mobile device with Clinical StudyPal’s solutions. For example, here are seven (7) ways to use automated SMS/messaging to increase

Informed consent is one of the founding principles of research ethics. Its intent is that human participants can partake in medical research freely (i.e., voluntarily) with full information about what it means for them to take part; and, that they give consent before they participate in the clinical research study. Electronic consent (eConsent), also known as electronic informed consent (eIC), is a method of obtaining informed consent through the use of an electronic system instead of a paper consent form. Technology solutions, like Delve Health’s Clinical StudyPal app, allow for a digital consent process that potential study participants

Can we say something more around why we are focusing on collecting raw data from Wearables? Wearables are being implemented in more and more clinical trials, and gaining steam in the healthcare world at-large. Deloitte predicts that 320 million consumer health and wellness wearable devices will ship worldwide in 2022. These devices enable a clinical study team to monitor their patients’ various health metrics, like daily steps, sleep quality, and heart rate, increasing patient compliance and retention. Delve Health offers a customizable technology solution to researchers and providers, opening up a whole new world of possibilities for data captured by

Wearables in clinical research is a “hot topic” and all the “buzz.” While many people feel it will propel the clinical research enterprise into the future, critics are sounding the alarm bells citing concerns of data privacy and AI technology in general. Whether we’re discussing smartwatches and fitness trackers to VR headsets, smart rings, smart glasses, and whatever else is on the horizon—there is no doubt that consumers have widely adopted wearables. Due of that wide-spread acceptance into our daily lives, wearables are changing how consumers communicate, monitor, and share information. Wearables in the Current Marketplace Wearable devices, in general

Defining eConsent in Clinical Trials The US Food and Drug Administration (FDA) has defined electronic informed consent (eConsent) in clinical trials as “the use of electronic systems and processes that may employ multiple electronic media, including text, graphics, audio, video, podcasts, passive and interactive websites, biological recognition devices, and card readers, to convey information related to the study to obtain and document informed consent.” How does eConsent Work in Clinical Trials? Delve Health’s Clinical StudyPal is a customizable solution that can be integrated into virtually any system or wearable device. Our platform is web-based and offers eConsent, in addition to